International Patent: TUMORIGENICITY SCORING FOR CANCER VACCINE DEVELOPMENT AND MEDICAL DECISION MAKING

GENEVA, Aug. 7 -- NEC LABORATORIES AMERICA, INC. filed a patent application (US2026/013315) for “TUMORIGENICITY SCORING FOR CANCER VACCINE DEVELOPMENT AND MEDICAL DECISION MAKING”. With publication no. WO/2026/165389, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16B 40/20

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....